214 related articles for article (PubMed ID: 36120293)
21. Methylene Homologues of Artemisone: An Unexpected Structure-Activity Relationship and a Possible Implication for the Design of C10-Substituted Artemisinins.
Wu Y; Wu RW; Cheu KW; Williams ID; Krishna S; Slavic K; Gravett AM; Liu WM; Wong HN; Haynes RK
ChemMedChem; 2016 Jul; 11(13):1469-79. PubMed ID: 27273875
[TBL] [Abstract][Full Text] [Related]
22. Assessment
Yipsirimetee A; Chiewpoo P; Tripura R; Lek D; Day NPJ; Dondorp AM; Pukrittayakamee S; White NJ; Chotivanich K
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0148121. PubMed ID: 34978886
[TBL] [Abstract][Full Text] [Related]
23. Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice.
Schlange C; Müller J; Imhof D; Hänggeli KPA; Boubaker G; Ortega-Mora LM; Wong HN; Haynes RK; Van Voorhis WC; Hemphill A
Exp Parasitol; 2023 Dec; 255():108655. PubMed ID: 37981259
[TBL] [Abstract][Full Text] [Related]
24. In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins.
Akoachere M; Buchholz K; Fischer E; Burhenne J; Haefeli WE; Schirmer RH; Becker K
Antimicrob Agents Chemother; 2005 Nov; 49(11):4592-7. PubMed ID: 16251300
[TBL] [Abstract][Full Text] [Related]
25. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
[TBL] [Abstract][Full Text] [Related]
26. Variation in terpenoids in leaves of Artemisia annua grown under different LED spectra resulting in diverse antimalarial activities against Plasmodium falciparum.
Sankhuan D; Niramolyanun G; Kangwanrangsan N; Nakano M; Supaibulwatana K
BMC Plant Biol; 2022 Mar; 22(1):128. PubMed ID: 35313811
[TBL] [Abstract][Full Text] [Related]
27. Antimalarial pharmacodynamics of chalcone derivatives in combination with artemisinin against Plasmodium falciparum in vitro.
Bhattacharya A; Mishra LC; Sharma M; Awasthi SK; Bhasin VK
Eur J Med Chem; 2009 Sep; 44(9):3388-93. PubMed ID: 19269069
[TBL] [Abstract][Full Text] [Related]
28. The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediates.
Haynes RK; Chan WC; Lung CM; Uhlemann AC; Eckstein U; Taramelli D; Parapini S; Monti D; Krishna S
ChemMedChem; 2007 Oct; 2(10):1480-97. PubMed ID: 17768732
[TBL] [Abstract][Full Text] [Related]
29. Artemisinin-independent inhibitory activity of
Ashraf K; Tajeri S; Arnold CS; Amanzougaghene N; Franetich JF; Vantaux A; Soulard V; Bordessoulles M; Cazals G; Bousema T; van Gemert GJ; Le Grand R; Dereuddre-Bosquet N; Barale JC; Witkowski B; Snounou G; Duval R; Botté CY; Mazier D
Life Sci Alliance; 2022 Mar; 5(3):. PubMed ID: 34857648
[TBL] [Abstract][Full Text] [Related]
30. Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus.
Oiknine-Djian E; Bar-On S; Laskov I; Lantsberg D; Haynes RK; Panet A; Wolf DG
Antiviral Res; 2019 Dec; 172():104639. PubMed ID: 31654672
[TBL] [Abstract][Full Text] [Related]
31. First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone.
Nagelschmitz J; Voith B; Wensing G; Roemer A; Fugmann B; Haynes RK; Kotecka BM; Rieckmann KH; Edstein MD
Antimicrob Agents Chemother; 2008 Sep; 52(9):3085-91. PubMed ID: 18559649
[TBL] [Abstract][Full Text] [Related]
32. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
33. In vitro dual activity of Aloe marlothii roots and its chemical constituents against Plasmodium falciparum asexual and sexual stage parasites.
Mianda SM; Invernizzi L; van der Watt ME; Reader J; Moyo P; Birkholtz LM; Maharaj VJ
J Ethnopharmacol; 2022 Oct; 297():115551. PubMed ID: 35850311
[TBL] [Abstract][Full Text] [Related]
34. In vitro inhibition of Plasmodium falciparum early and late stage gametocyte viability by extracts from eight traditionally used South African plant species.
Moyo P; Botha ME; Nondaba S; Niemand J; Maharaj VJ; Eloff JN; Louw AI; Birkholtz L
J Ethnopharmacol; 2016 Jun; 185():235-42. PubMed ID: 26994818
[TBL] [Abstract][Full Text] [Related]
35. Elimination of Schistosoma mansoni in infected mice by slow release of artemisone.
Gold D; Alian M; Domb A; Karawani Y; Jbarien M; Chollet J; Haynes RK; Wong HN; Buchholz V; Greiner A; Golenser J
Int J Parasitol Drugs Drug Resist; 2017 Aug; 7(2):241-247. PubMed ID: 28511056
[TBL] [Abstract][Full Text] [Related]
36. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
[TBL] [Abstract][Full Text] [Related]
37. Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum.
Sharma N; Mohanakrishnan D; Sharma UK; Kumar R; Richa ; Sinha AK; Sahal D
Eur J Med Chem; 2014 May; 79():350-68. PubMed ID: 24747290
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of artemisone and artemisinin derivatives against extracellular and intracellular Helicobacter pylori.
Sisto F; Scaltrito MM; Masia C; Bonomi A; Coccè V; Marano G; Haynes RK; Miani A; Farronato G; Taramelli D
Int J Antimicrob Agents; 2016 Jul; 48(1):101-105. PubMed ID: 27216383
[TBL] [Abstract][Full Text] [Related]
39. Differential effects on angiogenesis of two antimalarial compounds, dihydroartemisinin and artemisone: implications for embryotoxicity.
D'Alessandro S; Gelati M; Basilico N; Parati EA; Haynes RK; Taramelli D
Toxicology; 2007 Nov; 241(1-2):66-74. PubMed ID: 17897768
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, in vitro antimalarial activities and cytotoxicities of amino-artemisinin-ferrocene derivatives.
de Lange C; Coertzen D; Smit FJ; Wentzel JF; Wong HN; Birkholtz LM; Haynes RK; N'Da DD
Bioorg Med Chem Lett; 2018 Feb; 28(3):289-292. PubMed ID: 29317166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
